Sidabutar Roland, Hermanto Yulius, Sutiono Agung Budi, Naibaho Guata, Faried Ahmad
Department of Neurosurgery, Dr. Hasan Sadikin Hospital, Padjadjaran University, Bandung, West Java, Indonesia.
Surg Neurol Int. 2024 Nov 29;15:440. doi: 10.25259/SNI_685_2024. eCollection 2024.
Tuberculum sellae meningiomas (TSMs) represent a distinct entity among intracranial meningiomas. Both transcranial approaches (TCAs) and endoscopic endonasal approaches (EEAs) have provided neurosurgeons with options for managing these difficult tumors. Still, controversies persist regarding the selection criteria for the most optimal approach.
The authors retrospectively reviewed 45 patients treated surgically for TSM between 2018 and 2023. The clinical reports of all subjects were assessed pre-and post-operatively, encompassing demographic information, clinical symptoms, imaging results, ophthalmological evaluations, operative details, and any complications.
A total of 45 patients were included in this study, with 21 patients undergoing EEAs and 24 TCAs. TSMs treated with EEA are smaller than TCA ( = 0.0014), less prevalent in optic canal invasion ( = 0.0291) and in arterial encasement ( = 0.0050), and have no lateral extension ( < 0.0001). The majority of patients (36/45) had visual improvement or stabilization following the surgery, with the rate of achieving gross total resection (GTR) was higher in the EEA group (17/21) than in the TCA group (9/24) ( = 0.0032). The mortality tends to be higher in the TCA group and is related to arterial encasement, although statistically insignificant.
Both traditional TCAs and EEAs offer options for the surgical management of TSM, each with its advantages and limitations. Based on our experiences, several factors (lateral extension and arterial encasement) may guide the suitable approach, and multidisciplinary considerations, with the overarching goals of achieving maximal tumor resection and minimizing postoperative complications.
鞍结节脑膜瘤(TSMs)在颅内脑膜瘤中是一种独特的类型。经颅入路(TCAs)和内镜鼻内入路(EEAs)都为神经外科医生提供了处理这些疑难肿瘤的选择。然而,关于最佳入路的选择标准仍存在争议。
作者回顾性分析了2018年至2023年间接受手术治疗的45例TSM患者。对所有受试者的临床报告进行术前和术后评估,包括人口统计学信息、临床症状、影像学结果、眼科评估、手术细节及任何并发症。
本研究共纳入45例患者,其中21例行EEAs,24例行TCAs。EEA治疗的TSMs比TCA治疗的更小(P = 0.0014),视神经管侵犯(P = 0.0291)和动脉包裹(P = 0.0050)的发生率更低,且无外侧延伸(P < 0.0001)。大多数患者(36/45)术后视力改善或稳定,EEA组的全切率(GTR)(17/21)高于TCA组(9/24)(P =